MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis
USA - NASDAQ:MDLZ - US6092071058 - Common Stock
61.2 USD
-0.46 (-0.75%)
We assign a fundamental rating of 4 out of 10 to MDLZ. MDLZ was compared to 86 industry peers in the Food Products industry. While MDLZ has a great profitability rating, there are quite some concerns on its financial health. MDLZ has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
In the past year MDLZ had a positive cash flow from operations.
In the past 5 years MDLZ has always been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
MDLZ's Return On Assets of 5.13% is fine compared to the rest of the industry. MDLZ outperforms 74.42% of its industry peers.
MDLZ has a better Return On Equity (13.90%) than 81.40% of its industry peers.
MDLZ's Return On Invested Capital of 6.99% is fine compared to the rest of the industry. MDLZ outperforms 72.09% of its industry peers.
MDLZ had an Average Return On Invested Capital over the past 3 years of 7.83%. This is significantly below the industry average of 28.75%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 13.9% | ||
| ROIC | 6.99% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
With an excellent Profit Margin value of 9.81%, MDLZ belongs to the best of the industry, outperforming 84.88% of the companies in the same industry.
MDLZ's Profit Margin has declined in the last couple of years.
The Operating Margin of MDLZ (13.22%) is better than 79.07% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a Gross Margin of 32.55%. This is in the better half of the industry: MDLZ outperforms 74.42% of its industry peers.
MDLZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.22% | ||
| PM (TTM) | 9.81% | ||
| GM | 32.55% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
MDLZ has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.41 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score (2.41) which is comparable to the rest of the industry.
The Debt to FCF ratio of MDLZ is 7.30, which is on the high side as it means it would take MDLZ, 7.30 years of fcf income to pay off all of its debts.
MDLZ has a better Debt to FCF ratio (7.30) than 67.44% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that MDLZ is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.76, MDLZ is not doing good in the industry: 61.63% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 7.3 | ||
| Altman-Z | 2.41 |
ROIC/WACC0.94
WACC7.45%
2.3 Liquidity
MDLZ has a Current Ratio of 0.64. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.64, MDLZ is doing worse than 88.37% of the companies in the same industry.
MDLZ has a Quick Ratio of 0.64. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MDLZ (0.39) is worse than 80.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.39 |
3. Growth
3.1 Past
The earnings per share for MDLZ have decreased strongly by -10.37% in the last year.
The Earnings Per Share has been growing slightly by 6.91% on average over the past years.
The Revenue has been growing slightly by 3.14% in the past year.
The Revenue has been growing slightly by 7.09% on average over the past years.
EPS 1Y (TTM)-10.37%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-15.12%
Revenue 1Y (TTM)3.14%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%7.68%
3.2 Future
Based on estimates for the next years, MDLZ will show a small growth in Earnings Per Share. The EPS will grow by 4.92% on average per year.
MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.19% yearly.
EPS Next Y-10.81%
EPS Next 2Y-1.29%
EPS Next 3Y2.2%
EPS Next 5Y4.92%
Revenue Next Year5.22%
Revenue Next 2Y4.8%
Revenue Next 3Y4.37%
Revenue Next 5Y4.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
MDLZ is valuated rather expensively with a Price/Earnings ratio of 19.68.
MDLZ's Price/Earnings ratio is in line with the industry average.
MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.08.
With a Price/Forward Earnings ratio of 18.21, MDLZ is valued on the expensive side.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 66.28% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.09. MDLZ is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.68 | ||
| Fwd PE | 18.21 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.68 | ||
| EV/EBITDA | 15.64 |
4.3 Compensation for Growth
MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.85
EPS Next 2Y-1.29%
EPS Next 3Y2.2%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.28%, MDLZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.10, MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.30, MDLZ pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
5.2 History
The dividend of MDLZ is nicely growing with an annual growth rate of 10.52%!
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
66.77% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP66.77%
EPS Next 2Y-1.29%
EPS Next 3Y2.2%
NASDAQ:MDLZ (10/28/2025, 3:39:09 PM)
61.2
-0.46 (-0.75%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners88.19%
Inst Owner Change-0.03%
Ins Owners0.14%
Ins Owner Change0.32%
Market Cap79.19B
Revenue(TTM)37.10B
Net Income(TTM)3.64B
Analysts76.47
Price Target74.91 (22.4%)
Short Float %1.88%
Short Ratio3.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP66.77%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.87%
Min EPS beat(2)5.55%
Max EPS beat(2)10.18%
EPS beat(4)3
Avg EPS beat(4)6.73%
Min EPS beat(4)-3.07%
Max EPS beat(4)14.26%
EPS beat(8)7
Avg EPS beat(8)5.91%
EPS beat(12)11
Avg EPS beat(12)6.02%
EPS beat(16)13
Avg EPS beat(16)5.09%
Revenue beat(2)0
Avg Revenue beat(2)-1.25%
Min Revenue beat(2)-2.09%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.46%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.41%
Revenue beat(12)5
Avg Revenue beat(12)0.07%
Revenue beat(16)8
Avg Revenue beat(16)0.51%
PT rev (1m)-0.16%
PT rev (3m)1.78%
EPS NQ rev (1m)-2.46%
EPS NQ rev (3m)-11.47%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)-0.68%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.68 | ||
| Fwd PE | 18.21 | ||
| P/S | 2.13 | ||
| P/FCF | 27.68 | ||
| P/OCF | 19.02 | ||
| P/B | 3.02 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.64 |
EPS(TTM)3.11
EY5.08%
EPS(NY)3.36
Fwd EY5.49%
FCF(TTM)2.21
FCFY3.61%
OCF(TTM)3.22
OCFY5.26%
SpS28.68
BVpS20.24
TBVpS-13.82
PEG (NY)N/A
PEG (5Y)2.85
Graham Number37.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 13.9% | ||
| ROCE | 9.6% | ||
| ROIC | 6.99% | ||
| ROICexc | 7.19% | ||
| ROICexgc | 51.08% | ||
| OM | 13.22% | ||
| PM (TTM) | 9.81% | ||
| GM | 32.55% | ||
| FCFM | 7.71% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 7.3 | ||
| Debt/EBITDA | 3.17 | ||
| Cap/Depr | 98.04% | ||
| Cap/Sales | 3.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 66.77% | ||
| Profit Quality | 78.58% | ||
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.39 | ||
| Altman-Z | 2.41 |
F-Score5
WACC7.45%
ROIC/WACC0.94
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.37%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-15.12%
EPS Next Y-10.81%
EPS Next 2Y-1.29%
EPS Next 3Y2.2%
EPS Next 5Y4.92%
Revenue 1Y (TTM)3.14%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%7.68%
Revenue Next Year5.22%
Revenue Next 2Y4.8%
Revenue Next 3Y4.37%
Revenue Next 5Y4.19%
EBIT growth 1Y-22.49%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year11.05%
EBIT Next 3Y8.25%
EBIT Next 5Y8.23%
FCF growth 1Y-1.28%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y6.39%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.
What is the valuation status for MDLZ stock?
ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
What are the PE and PB ratios of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 19.68 and the Price/Book (PB) ratio is 3.02.
How financially healthy is MONDELEZ INTERNATIONAL INC-A?
The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.